0.000 0 (0%) 08-26 17:10 |
|
Open: | 0.000 |
High: | 0.000 |
Low: | 0.000 |
Pre. close: | 0.000 |
Volume: | 5,737,000 |
Avg. volume: | 0 |
MA (50): | 0.000 |
MA (200): | 0.010 |
Year high: | 2.000 |
Year low: | 0.000 |
Market cap: | 0(M) |
EPS: | -200 |
PE ratio: | -0 |
SELL | BUY |
HeikinAshi: | |
Kaufmans AMA: | |
Chandelier (20): | |
MA (5): | |
MA (50): | |
MACD (26,12,9): | |
Slow KDJ (14,3): | |
RSI (14): | |
CCI (20): |
Mon, 07 Oct 2024
Pharnext: towards the opening of liquidation proceedings - MarketScreener
Fri, 02 Aug 2024
Charcot-Marie-Tooth Disease Market Size to Reach USD 8,995.2 Million by 2034, Impelled by Custom-Made Orthotics and Braces - BioSpace
Mon, 11 Dec 2023
Pharnext blames ‘unexpected’ placebo results for lead neurological drug’s phase 3 failure - Fierce Biotech
Mon, 18 Sep 2023
Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - Pharnext, MedDay, HELIXMITH, ENCell, InFlectis, Addex, Augustine, DTx Pharma - Yahoo Finance
Mon, 03 Oct 2022
Pharnext Executes a Financing Agreement with Néovacs for EUR 20.7 million Net to Further Develop PXT3003 for Charcot-Marie-Tooth Disease Type 1A - Yahoo Finance
Fri, 19 Aug 2022
PXT3003 Aims to Become First Approved Therapeutic for Charcot-Marie-Tooth Disease - NeurologyLive
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.